Study Links COPD Steroid Use to 17 Health Risks
Long-Term HKMU Study Reveals Rising Health Risks of Oral Corticosteroid Use in Chronic Obstructive Pulmonary Disease
Tags: Hong Kong Metropolitan University, Hong Kong, Healthcare & Lifesciences
HKMU's long-term study on chronic obstructive pulmonary disease (COPD) reveals that patients using oral corticosteroids (OCS) face increased risks of 17 diseases, including cardiovascular disease, osteoporosis, and lung inflammation. The research, conducted with anonymized patient data from England, showed a higher dosage of OCSs correlating with more adverse health outcomes. The study emphasizes the need for alternative treatments to manage COPD and reduce OCS reliance. Applications include better patient care and informed treatment plans for COPD patients. The findings are crucial for healthcare professionals in minimizing OCS-related risks.
IP Type or Form Factor: Discovery & Research
TRL: 6 - prototype validated in intended environment
Industry or Tech Area: Healthcare Provider; Healthcare Consumer
